Cannabis Technologies Inc. (CANLF) 0.3700 $CANLF
If Big Pharma Isn't Nervous, It Should Be
ACCESSWIRE - Thu Jul 31, 9:54AM CDT
Early Stage Cannabis Technologies...Potentially The Next GW Pharma
If Big Pharma Isn't Nervous, It Should Be; Early Stage Cannabis Technologies...Potentially the Next GW Pharma
GlobeNewswire - Thu Jul 31, 9:10AM CDT
Deep in the brain, buried within the central nervous system as well as lymphatic tissues and organs throughout the body are cannabinoid receptors; patiently waiting to help address a myriad of diseases. With the advent of cannabis research and therapy development many patients will likely trigger them very soon.
Cannabis Stocks Moved Lower Last Week, but Novus & Terra Tech Were Smokin'
ACCESSWIRE - Mon Jul 28, 8:33AM CDT
WHITEFISH, MT / July 28, 2014 / The Marijuana Index(TM) moved lower last week after a modest 1.6% rise in bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) was offset by a significant 4.9% drop in MedBox Inc. (OTC: MDBX) shares.
Advocate Cheryl Shuman Discusses CBD Benefits and Cannabis Technologies on CTV Interview
ACCESSWIRE - Tue Jul 22, 11:05AM CDT
Whitefish, MT / July 22, 2014 / Cannabis Technologies Inc. (OTC:CANLF), a leading innovator of technology and science within the cannabis sector, was recently highlighted in a Canadian TV ("CTV"
interview discussing the benefits of medical marijuana. As an ovarian cancer survivor, Ms. Shuman has become a leading advocate for the ongoing legalization of cannabis and research conducted by companies in the space, particularly companies like Cannabis Technologies that are working to reduce the time to commercialize cannabis based therapies.
Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Cannabis Technologies: A "Junior GW" Play on Cannabinoid's Potential
ACCESSWIRE - Wed Jun 25, 8:27AM CDT
WHITEFISH, MT / June 25, 2014 / Cannabinoids are a diverse set of chemical compounds that act on cannabinoid receptors on cells that repress neurotransmitter release in the brain. While tetrahydrocannabinol ("THC" and cannabidiol ("CBD" are the two most popular cannabinoids, there are at least 85 different cannabinoids isolated from cannabis exhibiting various effects that could prove therapeutic.
Cannabis Technologies Announces Glaucoma Therapy Entering Into Phase 1 Clinical Trials
Marketwire - Tue Jun 24, 5:01AM CDT
Cannabis Technologies Inc. (CSE: CAN)(OTCQB: CANLF) is pleased to announce its first therapy, CT1-085, which is a topical formulation containing a proprietary compound of cannabinoids and non-cannabis based active ingredients for the treatment of Glaucoma.
Cannabis Technologies Appoints Dr. Tarek S. Mansour, Ph.D. to Scientific Advisory Board
Marketwire - Tue Jun 10, 5:31AM CDT
Cannabis Technologies Inc. (the company) (CSE: CAN)(OTCQB: CANLF) announces today that Tarek Mansour, Ph.D., a veteran executive of the Life Science sector, has joined its Scientific Advisory Board. Dr. Mansour has over 26 years of experience in drug discovery and development with senior leadership and management positions within the biotechnology and pharmaceutical sector.
Abattis to Speak at First Annual WeedStock Conference
ACCESSWIRE - Fri Jun 06, 1:07PM CDT
Vancouver, BC / ACCESSWIRE / June 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on North American medicinal markets, today announced that they will be presenting at the WeedStock conference presented by Marketfy. The conference will feature a robust lineup of the cannabis industry's foremost experts. Despite recent challenges facing the industry and its investors, widespread support of legalization across the country suggests that the cannabis industry is a viable long-term industry for investors.
Cannabis Technologies Commences Trading on OTCQB
Marketwire - Thu Jun 05, 2:04AM CDT
Cannabis Technologies Inc. (CSE: CAN)(OTCQB: CANLF) announces that as of June 04, 2014, its common stock will begin trading on OTC Markets Group's OTCQB venture stage marketplace ("OTCQB" under the symbol "CANLF".
Top Cannabis Experts To Speak at the First Annual WeedStock Conference, Presented by Marketfy
ACCESSWIRE - Tue Jun 03, 1:12PM CDT
Southfield, MI / ACCESSWIRE / June 3, 2014 / The industry-changing WeedStock conference, presented by Marketfy, is set to feature a robust lineup of foremost experts in the Cannabis industry. Despite recent challenges facing the industry and its investors, record high support of legalization across the country strongly indicates that the cannabis industry is a long-term investment.
If Big Pharma Isn't Nervous, It Should Be
ACCESSWIRE - Thu Jul 31, 9:54AM CDT
Early Stage Cannabis Technologies...Potentially The Next GW Pharma
If Big Pharma Isn't Nervous, It Should Be; Early Stage Cannabis Technologies...Potentially the Next GW Pharma
GlobeNewswire - Thu Jul 31, 9:10AM CDT
Deep in the brain, buried within the central nervous system as well as lymphatic tissues and organs throughout the body are cannabinoid receptors; patiently waiting to help address a myriad of diseases. With the advent of cannabis research and therapy development many patients will likely trigger them very soon.
Cannabis Stocks Moved Lower Last Week, but Novus & Terra Tech Were Smokin'
ACCESSWIRE - Mon Jul 28, 8:33AM CDT
WHITEFISH, MT / July 28, 2014 / The Marijuana Index(TM) moved lower last week after a modest 1.6% rise in bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) was offset by a significant 4.9% drop in MedBox Inc. (OTC: MDBX) shares.
Advocate Cheryl Shuman Discusses CBD Benefits and Cannabis Technologies on CTV Interview
ACCESSWIRE - Tue Jul 22, 11:05AM CDT
Whitefish, MT / July 22, 2014 / Cannabis Technologies Inc. (OTC:CANLF), a leading innovator of technology and science within the cannabis sector, was recently highlighted in a Canadian TV ("CTV"
interview discussing the benefits of medical marijuana. As an ovarian cancer survivor, Ms. Shuman has become a leading advocate for the ongoing legalization of cannabis and research conducted by companies in the space, particularly companies like Cannabis Technologies that are working to reduce the time to commercialize cannabis based therapies. Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Cannabis Technologies: A "Junior GW" Play on Cannabinoid's Potential
ACCESSWIRE - Wed Jun 25, 8:27AM CDT
WHITEFISH, MT / June 25, 2014 / Cannabinoids are a diverse set of chemical compounds that act on cannabinoid receptors on cells that repress neurotransmitter release in the brain. While tetrahydrocannabinol ("THC"
and cannabidiol ("CBD" are the two most popular cannabinoids, there are at least 85 different cannabinoids isolated from cannabis exhibiting various effects that could prove therapeutic. Cannabis Technologies Announces Glaucoma Therapy Entering Into Phase 1 Clinical Trials
Marketwire - Tue Jun 24, 5:01AM CDT
Cannabis Technologies Inc. (CSE: CAN)(OTCQB: CANLF) is pleased to announce its first therapy, CT1-085, which is a topical formulation containing a proprietary compound of cannabinoids and non-cannabis based active ingredients for the treatment of Glaucoma.
Cannabis Technologies Appoints Dr. Tarek S. Mansour, Ph.D. to Scientific Advisory Board
Marketwire - Tue Jun 10, 5:31AM CDT
Cannabis Technologies Inc. (the company) (CSE: CAN)(OTCQB: CANLF) announces today that Tarek Mansour, Ph.D., a veteran executive of the Life Science sector, has joined its Scientific Advisory Board. Dr. Mansour has over 26 years of experience in drug discovery and development with senior leadership and management positions within the biotechnology and pharmaceutical sector.
Abattis to Speak at First Annual WeedStock Conference
ACCESSWIRE - Fri Jun 06, 1:07PM CDT
Vancouver, BC / ACCESSWIRE / June 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on North American medicinal markets, today announced that they will be presenting at the WeedStock conference presented by Marketfy. The conference will feature a robust lineup of the cannabis industry's foremost experts. Despite recent challenges facing the industry and its investors, widespread support of legalization across the country suggests that the cannabis industry is a viable long-term industry for investors. Cannabis Technologies Commences Trading on OTCQB
Marketwire - Thu Jun 05, 2:04AM CDT
Cannabis Technologies Inc. (CSE: CAN)(OTCQB: CANLF) announces that as of June 04, 2014, its common stock will begin trading on OTC Markets Group's OTCQB venture stage marketplace ("OTCQB"
under the symbol "CANLF". Top Cannabis Experts To Speak at the First Annual WeedStock Conference, Presented by Marketfy
ACCESSWIRE - Tue Jun 03, 1:12PM CDT
Southfield, MI / ACCESSWIRE / June 3, 2014 / The industry-changing WeedStock conference, presented by Marketfy, is set to feature a robust lineup of foremost experts in the Cannabis industry. Despite recent challenges facing the industry and its investors, record high support of legalization across the country strongly indicates that the cannabis industry is a long-term investment.
